A Comparative Study on Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl for Optimal Dose to be Used in Elderly Patients Undergoing Day Case Lower Abdominal and Urologic Surgeries.

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 14, 2022

Primary Completion Date

June 16, 2023

Study Completion Date

December 5, 2023

Conditions
Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl
Interventions
DRUG

Pilocaine 2% (1.5 ml) and 25 ug fentany

"Patients will be randomly allocated into the study groups according to the list of random numbers. The study groups will be as follows:~* Group P1 (N 15): patients assigned to this group will receive intrathecal 30 mg (1.5 ml) of prilocaine 2% (Takipril, prilocaine hydrochloride 20 mg/mL, hyperbar, Sintetica) + 25 ug fentanyl (0.5 ml).~* Group P2 (N 15): patient assigned to this group will receive intrathecal 40 mg (2 ml) of prilocaine 2% + 25 ug fentanyl (0.5 ml).~* Group P3 (N 15): patient assigned to this group will receive intrathecal 50 mg (2.5 ml) of prilocaine 2% + 25 ug fentanyl (0.5 ml)."

Trial Locations (1)

11451

Ahmed Abdalla Mohamed, Cairo

All Listed Sponsors
collaborator

Norhan Abdel Aleem Ali

UNKNOWN

collaborator

Hagar Hassanein Refaee

UNKNOWN

collaborator

Ahmed Abdullah Fathi Mohamed Almadawi

UNKNOWN

lead

Cairo University

OTHER